Latest filing published 17 Jun 2019 for AIM ImmunoTech Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -78.6%Entry US$1,280.31 · Close at T+365 US$273.52
- -54.4%Entry US$2,902.04 · Close at T+365 US$1,322.99
- +0.0%Entry US$2,091.17 · Close at T+365 US$2,091.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adam Pascale: trading record in brief
Adam Pascale discloses dealings in AIM ImmunoTech Inc. to SEC (Form 4). The record holds 8 filings, for trades running from 16 February 2017 to 8 May 2019.
Purchases make up the whole of the open-market record (3 purchases, €21k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
In size, the median ticket on the buying side is €8,552. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -30.0%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 17 June 2019, reports a transaction in AIM ImmunoTech Inc. The last purchase on record was published on 23 July 2018, which is 3,031 days ago. Typically, a trade is published a median of 9 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Adam Pascale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 sharesCommon StockSEC:0001613377-19-000002:0
- 35,000 sharesCommon StockSEC:0001613377-19-000002:1
- 10 sharesSeries B Convertible Preferred StockSEC:0001613377-19-000001:0
- 50,000 sharesWarrantsSEC:0001613377-19-000001:1
- 2,500 shares0Common StockSEC:0001613377-18-000033:0
- 32,259 shares@ US$0.31100.0% of flowCommon StockSEC:0001613377-18-000017:0Canonical exit: 21 Oct 2018 (T+90)
- 15,873 shares@ US$0.6375.1% of flowCommon StockSEC:0001613377-17-000005:0Canonical exit: 31 Jul 2017 (T+90)
- 6,981 shares@ US$0.4624.9% of flowCommon StockSEC:0001613377-17-000001:0Canonical exit: 17 May 2017 (T+90)
8 of 8 declarations